News

Scientists form new Seattle biotech, backed by $12M. Fate Therapeutics

November 30, 2007 /

MATR Sponsor (view all)


The MDT Disadvantaged Business Enterprise (DBE) Program encourages and supports the participation of companies owned and controlled by socially and economically disadvantaged individuals in transportation contracts.

A group of scientists who specialize in stem cell biology have formed a new biotech company backed by $12 million in original venture capital.

Fate Therapeutics will be based in Seattle and consists of leading scientists including Randall Moon of the University of Washington, who’s director of the Institute for Stem Cell and Regenerative Medicine. Other scientists come from Stanford University, Harvard University and Scripps Research Institute.

Full Story: http://www.bizjournals.com/seattle/stories/2007/11/26/daily23.html?ana=from_rss

MATR Supporters (view all)


Bozeman is a rapidly growing city with a high quality of life in part due to the easy access to the outdoors, burgeoning tech industry, and cultural experiences it offers.

Montana Technology Innovation Partnership (MTIP)- Promoting Technology Commercialization in the State of Montana.

The Kalispell Chamber of Commerce is the longest-standing and leading advocate for the Flathead Valley community and business climate.
Posted in:

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.